Liver Fibrosis FibroTest ActiTest Panel

The liver can respond to long-term stress by building up scar-like tissue, a process broadly described as fibrosis, and it can also show varying degrees of ongoing activity. The FibroTest ActiTest panel gathers a set of routine blood markers and combines them, along with basic personal details, into scores that a clinician can use to help gauge these processes without an invasive procedure. It is one noninvasive way to look at questions that were traditionally explored in other ways.

The panel is done with a routine blood draw at a Quest patient service center. A phlebotomist collects a sample from a vein, usually in the arm, and the sample goes to the laboratory, where the component markers are measured and combined into the panel's scores. People follow any preparation instructions their ordering clinician provides, since some liver-related markers can be sensitive to recent circumstances.

It helps to understand what the panel is for. It offers an estimate that supports a clinician's assessment; it does not replace a clinician's judgment or the other tools they may use, such as imaging or direct evaluation. Several everyday factors can influence the underlying markers, so a clinician reads the scores in the context of a person's history, other results, and overall health rather than in isolation.

People who look into the FibroTest ActiTest panel are usually working with a clinician who is exploring liver health and wants a noninvasive way to help assess fibrosis and activity. It can be of interest when a clinician is following a situation over time and wants a repeatable blood-based measure to watch alongside other information.

Others come to the topic curious about noninvasive alternatives to older approaches and want to understand what the panel offers. In each case it is most meaningful within a clinician-guided plan, because the scores are designed to support an assessment rather than stand alone.

The panel looks at a group of routine blood markers and combines them into scores meant to help a clinician assess two related things: the degree of fibrosis, or scar-like change, and the level of ongoing activity in the liver. By calculating a combined view from established markers, it gives a clinician a noninvasive estimate to consider next to everything else they know about a person.

Because the scores are built from underlying markers that can move for many reasons, they are best understood as an aid to assessment rather than a definitive measure. A clinician weighs them thoughtfully within a larger picture.

Clinicians commonly use noninvasive panels like this to help assess liver fibrosis and activity and to follow how they change over time. Because the panel is blood-based and repeatable, it can be useful for watching trends within a person's care, alongside imaging, history, and other tests. It is one input a clinician weighs rather than a stand-alone conclusion, and it works best as part of a plan a clinician is already guiding.

No appointment is needed. People can walk into a Quest patient service center during open hours, and the draw itself is quick — a phlebotomist collects a small sample from a vein in the arm, and most visits wrap up in a few minutes. The laboratory measures the component markers and combines them into the panel's scores, which are posted to the account for review and discussion with a clinician who can place them in context.

Results will be emailed securely to you as a PDF.